Study guide
6.2 Carbon Dioxide Absorption: Soda Lime Chemistry, Desiccation, Carbon Monoxide & Compound A
NBCRNA CRNA Certified Registered Nurse Anesthetist NCE
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Cardiovascular, Respiratory & CNS Physiology & Pathophysiology
1.1 Cardiovascular Physiology, Hemodynamics & Ischemic Heart Disease 1.2 Respiratory Physiology, Lung Volumes & Chronic Pulmonary Pathophysiology 1.3 Central & Autonomic Nervous System Physiology & Neurological Disorders
2 Chapter 2: Hepatorenal, Endocrine & Hematologic/Immune Systems
2.1 Renal Physiology, Glomerular Filtration & Acid-Base Balance 2.2 Hepatic Physiology, Drug Clearance & Gastrointestinal Considerations 2.3 Endocrine Disorders, Hematology, Coagulation & Immune Mechanisms
3 Chapter 3: Anesthetic Pharmacology: Inhalation Agents, Intravenous Anesthetics & Sedatives
3.1 Inhalation Anesthetics: Uptake, Distribution, Blood/Gas Solubility & MAC 3.2 Intravenous Hypnotics: Propofol, Etomidate, Ketamine & Barbiturates 3.3 Opioid Agonists/Antagonists, Benzodiazepines & Reversal Pharmacology
4 Chapter 4: Anesthetic Pharmacology: Neuromuscular Blockers, Local Anesthetics & Physics
4.1 Neuromuscular Blocking Agents & Reversal: Anticholinesterases vs Sugammadex 4.2 Local Anesthetics: Mechanism, Potency, Toxicity (LAST) & Vasoconstrictors 4.3 Applied Physics, Gas Laws, Fluid Dynamics & Anesthesia Mathematics
5 Chapter 5: Anesthesia Delivery Systems & Gas Supplies
5.1 Medical Gas Supply Systems, Cylinders, Regulators & Safety Index Systems (PISS/DISS) 5.2 Anesthesia Machine High, Intermediate & Low Pressure Systems & Failsafe Mechanisms 5.3 Vaporizer Technology: Variable-Bypass vs Desflurane Vaporizers & Machine Checkout
6 Chapter 6: Breathing Circuits, CO2 Absorption & Ventilators
6.1 Breathing Circuits: Circle System, Mapleson Classifications & Dead Space 6.2 Carbon Dioxide Absorption: Soda Lime Chemistry, Desiccation, Carbon Monoxide & Compound A 6.3 Anesthesia Ventilators, Pressure/Volume Modes, APL Valves & Waste Gas Scavenging
7 Chapter 7: Airway Equipment & Advanced Airway Instrumentation
7.1 Face Masks, Supraglottic Airways (LMA Types) & Endotracheal Tubes 7.2 Direct Laryngoscopy (Mac/Miller) & Video Laryngoscopy 7.3 Fiberoptic Intubation, Bronchial Blockers, Double-Lumen Tubes & Surgical Airways
8 Chapter 8: Patient Monitoring, Hemodynamics & Electrosurgical Safety
8.1 Noninvasive Monitoring: Pulse Oximetry, Capnography Waveforms & Temperature 8.2 Invasive Hemodynamics: Arterial Lines, CVP & Pulmonary Artery Catheters 8.3 Neuromuscular Monitoring (TOF/PTC), Depth of Anesthesia (EEG/BIS) & Electrical Safety
9 Chapter 9: Preoperative Assessment, Risk Stratification & Preparation
9.1 Preoperative History, Physical Examination & ASA Physical Status Classification 9.2 Cardiac & Pulmonary Risk Stratification, Diagnostic Testing & Optimization 9.3 Preoperative Fasting Guidelines, Aspiration Prophylaxis & Premedication
10 Chapter 10: Fluid Management, Blood Component Therapy & Coagulation Monitoring
10.1 Crystalloids vs Colloids, Maintenance & Deficit Calculations 10.2 Blood Component Therapy, Transfusion Triggers & Massive Transfusion Protocols 10.3 Point-of-Care Coagulation: TEG, ROTEM & Perioperative Coagulopathies
11 Chapter 11: Airway Management Strategies & Difficult Airway Algorithms
11.1 Difficult Airway Assessment: Mallampati, Cormack-Lehane & Airway Predictors 11.2 ASA Difficult Airway Algorithm: Anticipated vs Unanticipated Difficult Airway 11.3 "Cannot Intubate, Cannot Oxygenate" (CICO) & Emergency Front-of-Neck Access (eFONA)
12 Chapter 12: General Anesthesia: Induction, Maintenance, Emergence & TIVA
12.1 Rapid Sequence Induction (RSI), Cricoid Pressure & Intubation Protocols 12.2 Balanced Anesthesia vs Total Intravenous Anesthesia (TIVA) Principles 12.3 Emergence, Extubation Criteria, Deep vs Awake Extubation & Laryngospasm
13 Chapter 13: Regional Anesthesia: Neuraxial Blocks
13.1 Spinal Anesthesia: Anatomy, Physiology, High Spinal & Complications 13.2 Epidural & Combined Spinal-Epidural (CSE) Techniques & PDPH 13.3 Neuraxial Anticoagulation Guidelines (ASRA) & Epidural Hematoma
14 Chapter 14: Regional Anesthesia: Peripheral Nerve Blocks & Ultrasound Guidance
14.1 Upper Extremity Peripheral Nerve Blocks: Interscalene, Supraclavicular, Axillary 14.2 Lower Extremity & Truncal Blocks: Femoral, Sciatic, TAP & ESP Blocks 14.3 Ultrasound Physics, Needle Visualization & LAST Rescue Protocols
15 Chapter 15: Perioperative Safety, Positioning, PACU, Ethics & Professional Practice
15.1 Surgical Positioning Complications: Nerve Injuries & Physiologic Changes 15.2 PACU Discharge Criteria, PONV Management, Hypoxemia & Emergence Delirium 15.3 Malignant Hyperthermia Protocol & Operating Room Crisis Management 15.4 CRNA Ethics, Informed Consent, Scope of Practice & Wellness Initiatives
16 Chapter 16: Obstetric & Gynecologic Anesthesia
16.1 Maternal Physiology & Pharmacokinetics Across Trimesters 16.2 Labor Analgesia & Anesthesia for Cesarean Delivery 16.3 Obstetric Emergencies: Preeclampsia, Hemorrhage & Amniotic Fluid Embolism 16.4 Nonobstetric Surgery in the Pregnant Patient
17 Chapter 17: Pediatric Anesthesia
17.1 Pediatric Anatomy, Physiology, Airway & Developmental Pharmacology 17.2 Pediatric Induction, Maintenance, Fluids & Emergence Agitation 17.3 Pediatric Respiratory Emergencies: Croup, Epiglottitis & Laryngospasm
18 Chapter 18: Geriatric, Bariatric & Ambulatory Anesthesia
18.1 Geriatric Physiology, Pharmacodynamics & Postoperative Delirium/POCD 18.2 Bariatric Anesthesia: Obesity Hypoventilation, OSA & Dosing Adjustments 18.3 Ambulatory Surgery Selection Criteria & ERAS Protocols
19 Chapter 19: Cardiac, Vascular & Thoracic Anesthesia
19.1 Valvular Heart Disease, CAD & Cardiopulmonary Bypass Management 19.2 Vascular Anesthesia: Carotid Endarterectomy & Aortic Cross-Clamping 19.3 Thoracic Anesthesia: One-Lung Ventilation & Hypoxic Pulmonary Vasoconstriction
20 Chapter 20: Neurosurgical, Intra-Abdominal, Extrathoracic, Head/Neck & Trauma Anesthesia
20.1 Neurosurgical Anesthesia: ICP Dynamics, Craniotomy & Venous Air Embolism 20.2 Intra-Abdominal, Laparoscopy & Endocrine Tumor Anesthesia (Pheochromocytoma, Carcinoid) 20.3 ENT/Shared Airway, Extrathoracic Procedures & Trauma/Burn Resuscitation
21 Chapter 21: Neurologic, Gastrointestinal & Substance-Related Pathophysiology and Pharmacology
21.1 Neurodegenerative & Demyelinating Disease and Antiparkinsonian Pharmacology 21.2 Gastrointestinal & Exocrine Pancreatic Disorders: Esophageal, Gastric, Pancreatitis & Malabsorption 21.3 Cannabinoids, Herbal Remedies & Dietary Supplements
22 Chapter 22: Imaging Safety, Patient Warming & Infusion Technology
22.1 Fluoroscopy, Radiography & Radiation Safety in Anesthetizing Locations 22.2 Patient Warming Equipment & Rapid Infusion Devices
23 Chapter 23: Pain Medicine: Theory, Chronic Pain & Interventional Procedures
23.1 Pain Theory: Nociception, Sensitization & Chronic Pain Pathophysiology 23.2 Chronic Pain Management, Medication-Assisted Therapy & the Opioid-Tolerant Patient 23.3 Interventional Pain Procedures & Anesthesia for Pain Management Cases
24 Chapter 24: Professional Practice: Research Ethics, Error Disclosure & Provider Infection Control
24.1 Research Ethics, IRB Oversight & Protection of Human Subjects 24.2 Disclosure of Errors and Injuries, Adverse Event Reporting & Just Culture 24.3 Provider Infection Control: PPE, Air Handling & Occupational Exposure
25 Chapter 25: Neurosurgical Subspecialty Procedures
25.1 Cerebral Aneurysm Clipping, AVM Resection & Subarachnoid Hemorrhage 25.2 Transsphenoidal Hypophysectomy & Pituitary Surgery 25.3 Stereotactic Procedures, Deep Brain Stimulation & Awake Craniotomy 25.4 CSF Diversion, Burr Holes, Ventriculoperitoneal Shunts & Decompressive Craniectomy
26 Chapter 26: Head, Neck, Nasal, Dental & Ophthalmic Anesthesia
26.1 Nasal & Sinus Surgery, Nasotracheal Intubation & Craniofacial Procedures 26.2 Dental, Orthodontic, Oral-Maxillofacial & Ophthalmic Anesthesia 26.3 Neck Tumors, Radical Neck Dissection, Lymph Node Biopsy & Thyroid/Parathyroid Surgery
27 Chapter 27: Orthopedic & Extremity Anesthesia
27.1 Total Joint Arthroplasty, Bone Cement Implantation Syndrome & Tourniquet Physiology 27.2 Closed Reduction, Hand and Foot Procedures & Intravenous Regional (Bier) Block
28 Chapter 28: Non-Operating-Room Anesthesia: Interventional, Imaging & Radiation Therapy
28.1 Interventional and Neurointerventional Radiology Anesthesia 28.2 Radiation Therapy, Diagnostic Imaging & MRI-Suite Anesthesia
29 Chapter 29: Special Populations: Substance Use Disorder, Immunocompromised & Oncology Patients
29.1 Acute Intoxication, Withdrawal Syndromes & Perioperative Complications 29.2 Anesthesia for the Immunocompromised & Oncology Patient
6.2 Carbon Dioxide Absorption: Soda Lime Chemistry, Desiccation, Carbon Monoxide & Compound A
Key Takeaways Explain This Topic AI
Carbon dioxide absorption is a three-step exothermic chemical neutralization: (1) CO₂ + H₂O ⇌ H₂CO₃, (2) H₂CO₃ + 2NaOH → Na₂CO₃ + 2H₂O + heat, and (3) Na₂CO₃ + Ca(OH)₂ → CaCO₃ + 2NaOH (regenerating the sodium hydroxide activator).
Standard soda lime comprises 76-81% calcium hydroxide [Ca(OH)₂], 14-19% water, 2-4% sodium hydroxide [NaOH] activator, and ~0.2% silica hardener (4-8 mesh granule size balancing surface area with resistance to gas flow).
Ethyl violet pH indicator shifts from colorless/white to deep violet when the granule pH falls below 10.3; resting an exhausted canister allows NaOH to diffuse to the granule surface, causing deceptive temporary de-colorization back to white without restoring chemical absorption capacity.
Desiccated (dry) strong-base absorbents degrade volatile anesthetics into toxic Carbon Monoxide (CO); degradation potential ranks Desflurane > Enflurane > Isoflurane >> Halothane / Sevoflurane (most severe after high dry gas flows over weekends).
Sevoflurane degradation by strong alkali bases produces Compound A (a vinyl ether nephrotoxin); accumulation is minimized by maintaining fresh gas flows ≥1-2 L/min and avoiding desiccated absorbents. Modern alkali-free absorbents (e.g., Amsorb Plus, Litholyme) completely eliminate CO and Compound A generation.
Last updated: August 2026
6.2 Carbon Dioxide Absorption: Soda Lime Chemistry, Desiccation, Carbon Monoxide & Compound A
In closed and semi-closed rebreathing circuits, chemical carbon dioxide absorption is mandatory to prevent hypercapnia and respiratory acidosis. Rebreathing exhaled gases conserves patient body heat, airway moisture, and costly volatile anesthetic agents. However, chemical interactions between volatile anesthetics and carbon dioxide absorbents can generate toxic degradation products, including Carbon Monoxide ( C O CO CO ) and Compound A.
1. Chemical Neutralization Reactions & Thermodynamics
Carbon dioxide is an acidic gas ( C O 2 CO_2 C O 2 ). When exhaled into the absorption canister, it dissolves in water to form carbonic acid ( H 2 C O 3 H_2CO_3 H 2 C O 3 ), which is subsequently neutralized by alkali metal hydroxides in an exothermic reaction (releasing heat and water vapor). +-------------------------------------------------------------------------+
- | SODA LIME NEUTRALIZATION CASCADE |
- +-------------------------------------------------------------------------+
- | |
- | Step 1: Carbon Dioxide Hydration (Rate-Limiting) |
- | CO₂ + H₂O ⇌ H₂CO₃ (Carbonic Acid) |
- | |
- | Step 2: Neutralization by Strong Base Activator |
- | H₂CO₃ + 2 NaOH ──► Na₂CO₃ + 2 H₂O + Heat |
- | |
- | Step 3: Calcium Hydroxide Reaction & Activator Regeneration |
- | Na₂CO₃ + Ca(OH)₂ ──► CaCO₃↓ + 2 NaOH (Regenerated) |
- | |
- | Net Reaction: |
- | CO₂ + Ca(OH)₂ ──► CaCO₃ (Precipitate) + H₂O + Heat |
- | (Exothermic: ~13,700 calories / 57.3 kJ per mole of CO₂ absorbed) |
- | |
- +-------------------------------------------------------------------------+
- The Critical Role of Water in Soda Lime
Water constitutes 14 % − 19 % 14\% - 19\% 14% − 19% of total soda lime weight.
Water provides the essential aqueous film on the granule surface required to dissolve gaseous C O 2 CO_2 C O 2 into H 2 C O 3 H_2CO_3 H 2 C O 3 .
Desiccation (drying out): If water content drops below 5 % 5\% 5% , the hydration of C O 2 CO_2 C O 2 fails, absorption capacity collapses, and dry strong bases ( NaOH \text{NaOH} NaOH , KOH \text{KOH} KOH ) become hyper-reactive toward volatile anesthetic molecules.
Soda Lime Composition & Granule Sizing
Component Percentage by Weight Functional Purpose in Absorbent Canister
Calcium Hydroxide [ Ca(OH) 2 \text{Ca(OH)}_2 Ca(OH) 2 ] 76 % − 81 % 76\% - 81\% 76% − 81% Primary bulk chemical reactant; binds neutralized carbonate as insoluble calcium carbonate ( CaCO 3 \text{CaCO}_3 CaCO 3 ).
Water [ H 2 O \text{H}_2\text{O} H 2 O ] 14 % − 19 % 14\% - 19\% 14% − 19% Solvent for carbonic acid formation; essential for initiating neutralization.
Sodium Hydroxide [ NaOH \text{NaOH} NaOH ] 2 % − 4 % 2\% - 4\% 2% − 4% Strong-base activator / catalyst; accelerates reaction velocity.
Potassium Hydroxide [ KOH \text{KOH} KOH ] 0 % 0\% 0% in modern lime ( 1 % − 2 % 1\% - 2\% 1% − 2% historically) Removed from modern absorbents due to extreme degradation of volatile agents into CO and Compound A.
Silica (Silicon Dioxide) / Kieselguhr ≈ 0.2 % \approx 0.2\% ≈ 0.2% Hardening agent; prevents granules from crumbling into fine alkaline powder (dust) that could cause bronchospasm.
Ethyl Violet Indicator 0.03 % 0.03\% 0.03% pH indicator dye; signals chemical exhaustion by turning purple when pH < 10.3 \text{pH} < 10.3 pH < 10.3 .
Granule Sizing: The 4-to-8 Mesh Standard
Absorbent granules are manufactured to a specific 4-to-8 mesh size (meaning the granules pass through a screen with 4 openings per linear inch but are retained by a screen with 8 openings per inch; granule diameter ≈ 2.5 − 5.0 mm \approx 2.5 - 5.0 \text{ mm} ≈ 2.5 − 5.0 mm ).
Why Mesh Size Matters:
If granules are too small ( > 8 >8 > 8 mesh): Surface area increases, but inter-granular air spaces shrink, creating excessive airway resistance to breathing.
If granules are too large ( < 4 <4 < 4 mesh): Airflow resistance is low, but total surface area drops, leading to channeling and rapid exhaustion.
Absorptive Capacity: 100 g of standard soda lime can absorb approximately 26 Liters 26 \text{ Liters} 26 Liters of C O 2 CO_2 C O 2 (or ≈ 15 − 20 hours \approx 15 - 20 \text{ hours} ≈ 15 − 20 hours of adult anesthesia per kilogram of absorbent under standard fresh gas flows).
- 2. Ethyl Violet Indicator Chemistry & The Regeneration Trap
- Mechanism of Ethyl Violet Color Shift
Ethyl violet is a substituted triphenylmethane dye with an alkaline transition range:
Fresh / Active Absorbent: High concentration of hydroxide ions ( O H − OH^- O H − from NaOH \text{NaOH} NaOH and Ca(OH) 2 \text{Ca(OH)}_2 Ca(OH) 2 ) maintains an alkaline granule surface pH > 10.3 > 10.3 > 10.3 , where ethyl violet is colorless (white) .
Exhausted Absorbent: As hydroxide ions are consumed and basic hydroxides convert to neutral carbonates ( CaCO 3 \text{CaCO}_3 CaCO 3 ), the pH falls < 10.3 < 10.3 < 10.3 . In this less alkaline environment, the indicator dye ionizes, turning deep violet/purple . Fresh Absorbent (pH > 10.3) Exhausted Absorbent (pH < 10.3)
- [High OH⁻ Concentration] ──────► [OH⁻ Consumed / Carbonates Formed]
- Color: WHITE / COLORLESS Color: DEEP VIOLET / PURPLE
Channeling & The "Resting" Regeneration Phenomenon +-------------------------------------------------------------------------+
- | THE DECEPTIVE SODA LIME REGENERATION TRAP |
- +-------------------------------------------------------------------------+
- | |
- | Exhausted Canister (Purple, pH <10.3) |
- | │ |
- | ▼ Canister Left Resting Overnight / Between Cases |
- | |
- | Slow Diffusion of Unreacted NaOH from Interior Core of Granule |
- | │ |
- | ▼ |
- | Alkaline NaOH reaches granule surface -> Surface pH rises >10.3 |
- | │ |
- | ▼ |
- | Indicator Converts Back to WHITE / COLORLESS |
- | |
- | CRITICAL WARNING: The canister is NOT REGENERATED! Total chemical |
- | absorption capacity remains exhausted. Within minutes of clinical gas |
- | flow, the thin surface NaOH is neutralized and the lime turns purple. |
- | |
- +-------------------------------------------------------------------------+
NCE Exam Trap — Ethyl Violet Photodeactivation & De-colorization:
Photodeactivation: Fluorescent room lighting degrades ethyl violet dye. An exhausted canister exposed to sunlight or OR lights can turn permanently white even though it is completely exhausted.
Clinical Standard: Never rely solely on visual inspection of canister color. Continuous capnographic monitoring of inspired CO₂ ( F i C O 2 > 0 mmHg FiCO₂ > 0 \text{ mmHg} F i C O 2 > 0 mmHg ) is the definitive gold standard for diagnosing absorbent exhaustion.
3. Carbon Monoxide (CO) Production from Desiccated Absorbents
When volatile anesthetics containing a difluoromethyl ether group ( − O C H F 2 -OCHF_2 − OC H F 2 ) pass through completely dry (desiccated) carbon dioxide absorbents containing strong bases ( NaOH \text{NaOH} NaOH or KOH \text{KOH} KOH ), base-catalyzed degradation occurs, liberating massive concentrations of lethal Carbon Monoxide ( C O CO CO ) (often > 10 , 000 ppm >10,000 \text{ ppm} > 10 , 000 ppm ). +-------------------------------------------------------------------------+
- | CARBON MONOXIDE PRODUCTION RANKING (DESICCATION) |
- +-------------------------------------------------------------------------+
- | |
- | DESFLURANE > ENFLURANE > ISOFLURANE >> HALOTHANE / SEVOFLURANE |
- | (Most CO) (Least/No CO) |
- | |
- +-------------------------------------------------------------------------+
- The Classic "Monday Morning Scenario"
Setup: On Friday afternoon, an anesthesia machine is left with high fresh gas flow running (e.g., 10 − 15 L/min 10 - 15 \text{ L/min} 10 − 15 L/min of dry O 2 O_2 O 2 or air) over the entire weekend.
Consequence: By Monday morning, the continuous flow of dry gas has completely stripped the water content of the soda lime ( < 5 % <5\% < 5% moisture).
First Case: An unsuspecting CRNA delivers general anesthesia with Desflurane or Isoflurane . Desiccated strong bases attack the anesthetic molecule, producing acute carbon monoxide poisoning.
Pathophysiology & Diagnostic Pitfalls of Intraoperative CO Poisoning
Carboxyhemoglobin ( C O H b COHb CO H b ): CO binds to hemoglobin with an affinity 200–250 times greater than oxygen, forming carboxyhemoglobin.
Left-Shifted Curve: CO shifts the oxyhemoglobin dissociation curve to the left (Haldane effect) , locking oxygen onto hemoglobin and preventing oxygen offloading at the tissue level.
Standard Pulse Oximeter ( S p O 2 SpO_2 Sp O 2 ) Failure: Standard dual-wavelength pulse oximeters (660 nm and 940 nm) cannot differentiate between oxyhemoglobin ( O 2 H b O_2Hb O 2 H b ) and carboxyhemoglobin ( C O H b COHb CO H b ) . Carboxyhemoglobin absorbs light similarly to O 2 H b O_2Hb O 2 H b at 660 nm, causing the pulse oximeter to read falsely normal or near-normal ( 98 % − 100 % 98\% - 100\% 98% − 100% ) in the presence of severe, life-threatening hypoxia. Diagnosis requires blood gas analysis with multi-wavelength CO-oximetry .
- 4. Compound A Production & Sevoflurane Degradation
- Chemical Mechanism & Nephrotoxicity
Sevoflurane (a fluoromethyl isopropyl ether) contains a hydrogen atom on its fluorinated carbon that is vulnerable to proton extraction by strong alkali bases. This reaction degrades Sevoflurane into Compound A (fluoromethyl-2,2-difluoro-1-[trifluoromethyl]vinyl ether) and trace amounts of Compound B through E . Sevoflurane + Alkali Base (NaOH / KOH / Baralyme)
- │
- ▼
- Compound A (Toxic Fluorinated Vinyl Ether)
- │
- ▼ Inhaled & Metabolized by Kidney
- Renal Cysteine S-Conjugate β-Lyase Pathway
- │
- ▼
- Necrosis of Renal Proximal Tubular Epithelium (ATN)
- Factors Increasing Compound A Production
Factor High-Risk Condition Physiologic Mechanism
Fresh Gas Flow (FGF) Low FGF ( < 1.0 L/min <1.0 \text{ L/min} < 1.0 L/min ) Low flow allows Sevoflurane to cycle repeatedly through the absorbent bed, allowing Compound A concentrations to accumulate ( > 25 − 50 ppm >25 - 50 \text{ ppm} > 25 − 50 ppm ).
Absorbent Type Barium hydroxide lime (Baralyme) > Soda Lime Stronger alkali bases accelerate beta-elimination of Sevoflurane. (Baralyme is banned).
Absorbent Temperature High Canister Temperature ( > 45 − 50 ∘ C >45 - 50^\circ\text{C} > 45 − 5 0 ∘ C ) Exothermic C O 2 CO_2 C O 2 neutralization increases kinetic reaction rates, multiplying Compound A output.
Absorbent Hydration Dry / Partially Desiccated Absorbent Absence of water accelerates basic catalytic cleavage.
Sevoflurane Concentration High Inspired Volatile % ( > 2 − 3 % >2 - 3\% > 2 − 3% for long cases) Direct substrate concentration effect.
FDA Recommendations for Sevoflurane Delivery
To prevent Compound A accumulation and potential nephrotoxicity:
Administer Sevoflurane with a minimum fresh gas flow of 1.0 L/min 1.0 \text{ L/min} 1.0 L/min for procedures lasting up to 2 hours .
Maintain fresh gas flow of at least 2.0 L/min 2.0 \text{ L/min} 2.0 L/min for procedures exceeding 2 hours .
Fresh gas flow should never be maintained at < 1.0 L/min <1.0 \text{ L/min} < 1.0 L/min when delivering Sevoflurane.
5. Modern Alkali-Free Carbon Dioxide Absorbents
To eliminate the dual risks of Carbon Monoxide generation and Compound A formation, modern anesthesia practice has shifted toward strong-base-free (alkali-free) absorbents. +-------------------------------------------------------------------------+
- | COMPARISON OF CO₂ ABSORBENT GENERATIONS |
- +-------------------------------------------------------------------------+
- | Feature | Soda Lime | Amsorb Plus / Litholyme |
- +---------------------+-----------------------+---------------------------+
- | Strong Bases | NaOH (2-4%), KOH (0%) | ZERO (No NaOH, No KOH) |
- | Main Reactant | Ca(OH)₂ (76-81%) | Ca(OH)₂ + CaCl₂ / LiOH |
- | CO Generation | High (when dry) | ZERO (Even if bone dry) |
- | Compound A Formation| Yes (with Sevo) | ZERO (With Sevo) |
- | Canister Fires | Rare with Baralyme/Sevo| IMPOSSIBLE |
- | Indicator Color | Reversible (White) | Permanent Color Change |
- | Absorption Capacity | High (~26 L CO₂/100g) | Moderate (~12-18 L CO₂/100g|
- +---------------------+-----------------------+---------------------------+
Key Benefits of Modern Calcium Hydroxide Absorbents (e.g., Amsorb Plus):
Zero Strong Bases: Contains calcium hydroxide with calcium chloride and calcium sulfate as hardeners, entirely free of sodium hydroxide and potassium hydroxide.
No Carbon Monoxide or Compound A: Does not degrade Desflurane into CO or Sevoflurane into Compound A, even if the absorbent becomes 100 % 100\% 100% desiccated.
Permanent Color Indication: Ethyl violet color change does not revert to white when resting, eliminating the deceptive regeneration trap.